Minnesota system treating atrial fibrillation helped sustain Boston Scientific’s streak of bullish results as the company ...
BTIG analyst Marie Thibault maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $120.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback